Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |